These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 12825176

  • 1. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection.
    Eng HL, Chen CH, Kuo CC, Wu JS, Wang CH, Lin TM.
    J Infect Dis; 2003 Jul 01; 188(1):90-7. PubMed ID: 12825176
    [Abstract] [Full Text] [Related]

  • 2. The association of C (-260)-->T polymorphism in CD14 promoter and Chlamydia pneumoniae infection in ischemic stroke patients.
    Lin TM, Chen CH, Wu HL, Wang CH, Chen YL, Eng HL.
    Am J Clin Pathol; 2008 Oct 01; 130(4):595-601. PubMed ID: 18794053
    [Abstract] [Full Text] [Related]

  • 3. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production.
    Eng HL, Wang CH, Chen CH, Chou MH, Cheng CT, Lin TM.
    Genes Immun; 2004 Aug 01; 5(5):426-30. PubMed ID: 15164100
    [Abstract] [Full Text] [Related]

  • 4. CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes.
    Rupp J, Goepel W, Kramme E, Jahn J, Solbach W, Maass M.
    Genes Immun; 2004 Aug 01; 5(5):435-8. PubMed ID: 15175649
    [Abstract] [Full Text] [Related]

  • 5. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
    Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B.
    Hepatogastroenterology; 2005 Aug 01; 52(63):808-11. PubMed ID: 15966209
    [Abstract] [Full Text] [Related]

  • 6. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.
    Järveläinen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO.
    Hepatology; 2001 May 01; 33(5):1148-53. PubMed ID: 11343243
    [Abstract] [Full Text] [Related]

  • 7. Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels.
    Heesen M, Blömeke B, Schlüter B, Heussen N, Rossaint R, Kunz D.
    Intensive Care Med; 2001 Nov 01; 27(11):1770-5. PubMed ID: 11810121
    [Abstract] [Full Text] [Related]

  • 8. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population.
    Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dörfer C, Grau A.
    J Neurol; 2002 Jul 01; 249(7):821-3. PubMed ID: 12140663
    [Abstract] [Full Text] [Related]

  • 9. Polymorphism in the promoter region of the CD14 gene and susceptibility to Brucellosis.
    Haidari M, Hajilooi M, Rezazadeh M, Rafiei A, Alavi SA, Keramat F.
    Immunol Invest; 2006 Jul 01; 35(2):239-45. PubMed ID: 16698680
    [Abstract] [Full Text] [Related]

  • 10. Effects of CD14, TLR2, TLR4, LPB, and IL-6 gene polymorphisms on Chlamydia pneumoniae growth in human macrophages in vitro.
    Poikonen K, Lajunen T, Silvennoinen-Kassinen S, Leinonen M, Saikku P.
    Scand J Immunol; 2009 Jul 01; 70(1):34-9. PubMed ID: 19522765
    [Abstract] [Full Text] [Related]

  • 11. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease.
    Griga T, Wilkens C, Schmiegel W, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Klein W.
    Eur J Med Res; 2005 May 20; 10(5):183-6. PubMed ID: 15946916
    [Abstract] [Full Text] [Related]

  • 12. The -260 C-->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients.
    Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M.
    Intensive Care Med; 2002 Aug 20; 28(8):1161-3. PubMed ID: 12185442
    [Abstract] [Full Text] [Related]

  • 13. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases.
    Kabesch M, Hasemann K, Schickinger V, Tzotcheva I, Bohnert A, Carr D, Baldini M, Hackstein H, Leupold W, Weiland SK, Martinez FD, Mutius E, Bein G.
    Allergy; 2004 May 20; 59(5):520-5. PubMed ID: 15080833
    [Abstract] [Full Text] [Related]

  • 14. CD14 C (-260)T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins.
    Giacconi R, Caruso C, Lio D, Muti E, Cipriano C, Costarelli L, Saba V, Gasparini N, Malavolta M, Mocchegiani E.
    Int J Cardiol; 2007 Aug 09; 120(1):45-51. PubMed ID: 17098305
    [Abstract] [Full Text] [Related]

  • 15. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes.
    Arroyo-Espliguero R, El-Sharnouby K, Vázquez-Rey E, Kalidas K, Jeffery S, Kaski JC.
    Int J Cardiol; 2005 Feb 15; 98(2):307-12. PubMed ID: 15686783
    [Abstract] [Full Text] [Related]

  • 16. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.
    Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, Imayoshi M, Ishii E, Tasaki H, Hamasaki Y.
    J Pediatr; 2003 Sep 15; 143(3):357-62. PubMed ID: 14517520
    [Abstract] [Full Text] [Related]

  • 17. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis.
    Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY.
    J Infect Dis; 2007 Dec 01; 196(11):1698-706. PubMed ID: 18008256
    [Abstract] [Full Text] [Related]

  • 18. CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases.
    Rechciński T, Grebowska A, Kurpesa M, Peruga Z, Dziuba M, Krzemińska-Pakuła M, Rudnicka W, Chmiela M.
    Kardiol Pol; 2007 Mar 01; 65(3):237-44; discussion 245. PubMed ID: 17436151
    [Abstract] [Full Text] [Related]

  • 19. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
    Bernardo E, Angiolillo DJ, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C, Fernandez-Ortiz A.
    Am J Cardiol; 2006 Nov 01; 98(9):1182-4. PubMed ID: 17056323
    [Abstract] [Full Text] [Related]

  • 20. The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality.
    Hubacek JA, Stüber F, Fröhlich D, Book M, Wetegrove S, Rothe G, Schmitz G.
    Genes Immun; 2000 Aug 01; 1(6):405-7. PubMed ID: 11196689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.